Naoki Kawahara, Shoichiro Yamanaka, Kyohei Nishikawa, Motoki Matsuoka, Tomoka Maehana, Ryuji Kawaguchi, Naoki Ozu, Tomomi Fujii, Aya Sugimoto, Akihiko Yoshizawa, et al. Endogenous Microbacteria Can Contribute to Ovarian Carcinogenesis by Reducing Iron Concentration in Cysts: A Pilot Study. Microorganisms. 2024. 12. 3
Naoki Kawahara, Ryuji Kawaguchi, Konosuke Yamamoto, Kyohei Nishikawa, Motoki Matsuoka, Tomoka Maehana, Yosuke Fukui, Shoichiro Yamanaka, Sumire Sugimoto, Kana Iwai, et al. The clinical trial of alternative relugolix administration for uterine leiomyoma prior to surgically treatment: a study protocol for Non-Adverse Relugolix Administration (NARA) trial. Trials. 2024. 25. 1. 68-68
Ryuji Kawaguchi, Tomoka Maehana, Shoichiro Yamanaka, Ryuta Miyake, Naoki Kawahara, Kana Iwai, Yuki Yamada, Fuminori Kimura. Preoperative serum tissue factor pathway inhibitor-2 level as a prognostic marker for endometrial cancer. Oncology letters. 2023. 26. 5. 463-463
Naoki Kawahara, Shoichiro Yamanaka, Sumire Sugimoto, Junya Kamibayashi, Kyohei Nishikawa, Ryuji Kawaguchi, Fuminori Kimura. The Prognosis Predictive Score around Neo Adjuvant Chemotherapy (PPSN) Improves Diagnostic Efficacy in Predicting the Prognosis of Epithelial Ovarian Cancer Patients. Cancers. 2023. 15. 20
Naoki Kawahara, Ryuji Kawaguchi, Keita Waki, Tomoka Maehana, Shoichiro Yamanaka, Yuki Yamada, Fuminori Kimura. The prognosis predictive score around primary debulking surgery (PPSP) improves diagnostic efficacy in predicting the prognosis of ovarian cancer. Scientific reports. 2022. 12. 1. 22636-22636